Medical Oncology

雜志介紹

Medical Oncology雜志介紹

《Medical Oncology》是一本以English為主的未開放獲取國際優秀期刊，中文名稱醫學腫瘤學，本刊主要出版、報道醫學-ONCOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.8，最新CiteScore 指數為4.2。

本刊近期中國學者發表的論文主要有：

• ErbB2-upregulated HK1 and HK2 promote breast cancer cell proliferation, migration and invasion

  Author: Ma, Xuejiao; Chen, Jingruo; Huang, Bohan; Fu, Shiqi; Qu, Shuai; Yu, Rong; Zhao, Yuhua

• Classification of triple-negative breast cancer based on pathway enrichment levels

  Author: Liu, Qian; Wang, Xiaosheng

• P4HA3 promotes clear cell renal cell carcinoma progression via the PI3K/AKT/GSK3 beta pathway

  Author: Zhang, Zhechuan; Zhang, Yuanfeng; Zhang, Ronggui

• Downregulation of CEMIP enhances radiosensitivity by promoting DNA damage and apoptosis in colorectal cancer

  Author: Weng, Jiawen; Zhang, Yuqin; Liang, Weijie; Xie, Yuwen; Wang, Kai; Xu, Qian; Ding, Yi; Li, Yiyi

英文介紹

Medical Oncology雜志英文介紹

Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly experimental therapeutics within the fields of immunotherapy and chemotherapy. It also provides state-of-the-art reviews on clinical and experimental therapies. Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors.